Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

BACKGROUND AND PURPOSE—Patients with atrial fibrillation and previous ischemic stroke (IS)/transient ischemic attack (TIA) are at high risk of recurrent cerebrovascular events despite anticoagulation. In this prespecified subgroup analysis, we compared warfarin with edoxaban in patients with versus...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2016-08, Vol.47 (8), p.2075-2082
Hauptverfasser:	Rost, Natalia S, Giugliano, Robert P, Ruff, Christian T, Murphy, Sabina A, Crompton, Andrea E, Norden, Andrew D, Silverman, Scott, Singhal, Aneesh B, Nicolau, José C, SomaRaju, Bhupathi, Mercuri, Michele F, Antman, Elliott M, Braunwald, Eugene
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - therapeutic use Atrial Fibrillation - drug therapy Atrial Fibrillation - prevention & control Brain Ischemia - drug therapy Brain Ischemia - prevention & control Double-Blind Method Female Humans Male Middle Aged Pyridines - therapeutic use Recurrence Secondary Prevention Stroke - drug therapy Stroke - prevention & control Thiazoles - therapeutic use Treatment Outcome Warfarin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!